BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15547786)

  • 1. Involvement of the sigma1 receptor in the appetitive effects of cocaine.
    Maurice T; Romieu P
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S198-207. PubMed ID: 15547786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects.
    Toussaint M; Delair B; Foulon C; Lempereur N; Vaccher C; Maurice T; Melnyk P
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):504-15. PubMed ID: 19249191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward.
    Martin-Fardon R; Maurice T; Aujla H; Bowen WD; Weiss F
    Neuropsychopharmacology; 2007 Sep; 32(9):1967-73. PubMed ID: 17268407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in fos-related antigen 2 and sigma1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies.
    Liu Y; Matsumoto RR
    J Pharmacol Exp Ther; 2008 Oct; 327(1):187-95. PubMed ID: 18591217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sigma ligands on the cocaine-induced convulsions in mice.
    Skuza G
    Pol J Pharmacol; 1999; 51(6):477-83. PubMed ID: 10817525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade.
    Romieu P; Phan VL; Martin-Fardon R; Maurice T
    Neuropsychopharmacology; 2002 Apr; 26(4):444-55. PubMed ID: 11927169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction.
    Fritz M; Klement S; El Rawas R; Saria A; Zernig G
    Pharmacology; 2011; 87(1-2):45-8. PubMed ID: 21196793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
    Thompson BE; Sachs BD; Kantak KM; Cherry JA
    Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
    Koeltzow TE; Vezina P
    Behav Brain Res; 2005 May; 160(2):250-9. PubMed ID: 15863221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC; McCracken KA; Liu Y; Pouw B; Matsumoto RR
    Neuropharmacology; 2005 Oct; 49(5):638-45. PubMed ID: 15939443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-hydroxybutyric acid affects the acquisition and reinstatement of cocaine-induced conditioned place preference in mice.
    Maldonado C; Rodríguez-Arias M; Castillo A; Aguilar MA; Miñarro J
    Behav Pharmacol; 2006 Mar; 17(2):119-31. PubMed ID: 16495720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sigma Receptor antagonists block the development of sensitization to cocaine.
    Ujike H; Kuroda S; Otsuki S
    Eur J Pharmacol; 1996 Jan; 296(2):123-8. PubMed ID: 8838447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference.
    Maldonado C; Rodríguez-Arias M; Castillo A; Aguilar MA; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):932-9. PubMed ID: 17395352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.
    Fukushiro DF; Alvarez Jdo N; Tatsu JA; de Castro JP; Chinen CC; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):867-72. PubMed ID: 17368685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
    Velázquez-Sánchez C; Ferragud A; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A; Kulkarni SK
    Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
    Erb S; Funk D; Lê AD
    Neurosci Lett; 2005 Aug; 383(3):209-14. PubMed ID: 15955413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference.
    Bahi A; Kusnecov AW; Dreyer JL
    Behav Brain Res; 2008 Aug; 191(1):17-25. PubMed ID: 18436315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
    Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP
    Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Fundam Clin Pharmacol; 2008 Aug; 22(4):387-94. PubMed ID: 18705749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.